1. Home
  2. PTGX vs SHO Comparison

PTGX vs SHO Comparison

Compare PTGX & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • SHO
  • Stock Information
  • Founded
  • PTGX 2006
  • SHO 1995
  • Country
  • PTGX United States
  • SHO United States
  • Employees
  • PTGX N/A
  • SHO 36
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • SHO Hotels/Resorts
  • Sector
  • PTGX Health Care
  • SHO Consumer Discretionary
  • Exchange
  • PTGX Nasdaq
  • SHO Nasdaq
  • Market Cap
  • PTGX 3.3B
  • SHO 1.7B
  • IPO Year
  • PTGX 2016
  • SHO 1995
  • Fundamental
  • Price
  • PTGX $53.00
  • SHO $9.16
  • Analyst Decision
  • PTGX Strong Buy
  • SHO Hold
  • Analyst Count
  • PTGX 9
  • SHO 8
  • Target Price
  • PTGX $67.11
  • SHO $9.56
  • AVG Volume (30 Days)
  • PTGX 923.4K
  • SHO 2.8M
  • Earning Date
  • PTGX 08-05-2025
  • SHO 08-06-2025
  • Dividend Yield
  • PTGX N/A
  • SHO 3.95%
  • EPS Growth
  • PTGX N/A
  • SHO N/A
  • EPS
  • PTGX 0.86
  • SHO 0.10
  • Revenue
  • PTGX $207,801,000.00
  • SHO $922,708,000.00
  • Revenue This Year
  • PTGX N/A
  • SHO $7.67
  • Revenue Next Year
  • PTGX $53.09
  • SHO $3.45
  • P/E Ratio
  • PTGX $61.48
  • SHO $92.87
  • Revenue Growth
  • PTGX N/A
  • SHO N/A
  • 52 Week Low
  • PTGX $32.50
  • SHO $7.45
  • 52 Week High
  • PTGX $60.60
  • SHO $12.41
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 53.99
  • SHO 59.10
  • Support Level
  • PTGX $49.38
  • SHO $8.70
  • Resistance Level
  • PTGX $51.51
  • SHO $9.30
  • Average True Range (ATR)
  • PTGX 2.02
  • SHO 0.24
  • MACD
  • PTGX -0.39
  • SHO 0.04
  • Stochastic Oscillator
  • PTGX 46.09
  • SHO 83.57

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its hotel ownership segment.

Share on Social Networks: